Market Cap (In INR)
64.68 Billion
Revenue (In INR)
40.51 Billion
Net Income (In INR)
-706.14 Million
Avg. Volume
393.94 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 571.0-1675.0
- PE
- -
- EPS
- -
- Beta Value
- 0.73
- ISIN
- INE939A01011
- CUSIP
- Y8175G117
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Badree Komandur
- Employee Count
- -
- Website
- https://www.strides.com
- Ipo Date
- 2002-06-26
- Details
- Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
More Stocks
-
2459Audix Corporation
2459
-
6456
-
TVK
-
VRLLOGVRL Logistics Limited
VRLLOG
-
WOCKPHARMAWockhardt Limited
WOCKPHARMA
-
ASBFY
-
PEB
-
STMGFStamper Oil & Gas Corp.
STMGF